Inspire Medical Systems, Inc. Earnings Recaps
Q3 2025
Nov 6, 2025
Inspire Medical Systems delivered robust third-quarter results, with revenue rising 10% year-over-year to $224.5 million, supported by strong patient adoption and favorable reimbursement developments.
Key takeaways
- Operating income reached $9.6 million, with earnings per share guidance upgraded to $0.90–$1.00, reflecting improved cost discipline and revenue growth.
- Physician training for the Inspire V system is over 98% complete, and contracting is over 90% finalized, positioning the company for a successful product launch.
- Recent clinical studies highlighted Inspire’s effectiveness in reducing long-term cardiovascular risks in OSA patients, reinforcing the company's commitment to innovation and patient outcomes.